Patrycja Zielińska,Karolina Gruenpeter,Agata Wieczorkiewicz-Kabut et al.
Patrycja Zielińska et al.
Second allogeneic stem cell transplantation (SCT2) presents a potentially curative treatment approach in patients who relapsed after first allogeneic transplant procedure. Currently there is no consensus on second allografting. The aim of o...
High NK cell counts at day 90 predict improved survival in event-free patients after T-cell depleted allogeneic stem cell transplantation [0.03%]
Andrej Pešić,Nevena Bešević,Nicolaus Kröger et al.
Andrej Pešić et al.
Lymphocyte subset counts were obtained from 70 patients undergoing in vivo T-cell depleted allogeneic transplantation from 2018 to 2024....Conclusion: The results suggest that high NK cell counts on day 90 after T-cell depleted allogeneic transplantation independently protect from NRM and improve OS in patients without prior major post-transplant complications.
CAR-T cells targeting CCR9 and CD1a for the treatment of T cell acute lymphoblastic leukemia [0.03%]
靶向CCR9和CD1a的CAR-T细胞治疗T细胞急性淋巴细胞白血病
Néstor Tirado,Klaudyna Fidyt,María José Mansilla et al.
Néstor Tirado et al.
Dual CD1a/CCR9 CAR-T therapy may prevent T cell aplasia and obviate the need for allogeneic transplantation and regulatory-challenging genome engineering approaches in T-ALL. © 2025. The Author(s).
Development of an ensemble prediction model for acute graft-versus-host disease in allogeneic transplantation based on machine learning [0.03%]
基于机器学习的异基因移植急性移植物抗宿主病列队预测模型构建
Lin Song,Xingwei Wu,Mengjia Xu et al.
Lin Song et al.
Background: Acute graft-versus-host disease (aGVHD) is a major post-transplantation complication and one of the most significant causes of non-relapse-related death. However, the massive and complex clinical data make aGV...
[Selection of blood products to reduce immunization before HLA-mismatched allogeneic transplantation (SFGM-TC)] [0.03%]
[选择血制品以减少人类白细胞抗原不相配的异基因移植前免疫化（SFGM-TC）]
Roberto Crocchiolo,Maude Avias,Caroline Baud et al.
Roberto Crocchiolo et al.
The increase of HLA-mismatched allogeneic stem cell transplantation, due to the use of post-transplant high-dose cyclophosphamide, has highlighted the detrimental impact of anti-HLA antibodies in the recipient, especially those directed aga...
Practice Guideline
Bulletin du cancer. 2025 Jun 28:S0007-4551(25)00262-0. DOI:10.1016/j.bulcan.2025.03.016 2025
Daratumumab plus bortezomib and dexamethasone as a bridge to allogeneic transplantation in refractory T-cell lymphoblastic lymphoma [0.03%]
达雷妥尤单抗联合硼替佐米和地塞米松用于难治性T细胞淋巴母细胞淋巴瘤的移植过渡治疗
Alessio Maria Edoardo Maraglino,Simona Sammassimo,Ginevra Lolli et al.
Alessio Maria Edoardo Maraglino et al.
Relapsed and refractory (r/r) T-cell lymphoblastic lymphoma (T-LBL) is a highly lethal disease, with no effective treatment options. Daratumumab, an anti-CD38 human IgG1κ monoclonal antibody has been used as single agent in CD38 positive r...
Clinical Characteristics and Treatment Outcomes of Acute Myeloid Leukemia in Adolescent and Young Adult versus Adult Patients: A Single-Center Experience in Qatar [0.03%]
卡塔尔单中心年轻成人急性髓系白血病患者与成人患者的临床特征及治疗结局的比较研究
Shehab Fareed,Abdulrahman Fadhl Al-Mashdali,Hawraa Shwaylia et al.
Shehab Fareed et al.
AYA patients received more intensive therapy, with higher rates of FLAG-Ida salvage therapy (34% versus 15%) and allogeneic transplantation (32% versus 15%, p=0.01). While transplantation significantly improved survival in adults, its impact was less pronounced in AYA patients.
Allogenic mitochondria transfer improves cardiac function in iPS-cell-differentiated cardiomyocytes of a patient with Barth syndrome [0.03%]
同种线粒体转移改善了巴尔特氏病患者诱导多能干细胞分化的心肌细胞的功能
Ye Seul Kim,Sukdong Yoo,Yoon Ji Jung et al.
Ye Seul Kim et al.
These results suggest that normal CMs are useful for allogeneic transplantation in the treatment of mitochondrial diseases, including BTHS. © 2025. The Author(s).
The Role of Allogeneic Stem Cell Transplantation in Adult Patients With Peripheral T-Cell Lymphoma: A Systematic Review and Meta-Analysis [0.03%]
异基因干细胞移植治疗成人外周T细胞淋巴瘤患者的疗效分析：系统评价和Meta分析
Ahmad Alazzam,Mosab Said,Mohammad AlElaimat et al.
Ahmad Alazzam et al.
Both autologous and allogeneic stem cell transplants have been used, although allogeneic transplantation is preferred for resistant cases....This systematic review and meta-analysis aim to clarify the impact of allogeneic transplantation on survival and treatment outcomes in PTCL patients.
The impact of second allogeneic hematopoietic stem cell transplantation as salvage therapy for hematologic diseases after a first allogeneic transplantation [0.03%]
首次异基因造血干细胞移植后挽救性二次移植物植入的疗效及危险因素分析
Hikmetullah Batgi,Tuğba Zorlu,Mehmet Ali Erkurt et al.
Hikmetullah Batgi et al.
Background and objectives: Acute leukemia patients who relapse after the first allogeneic stem-cell transplantation (HSCT1) have a poor prognosis. Second allogeneic hematopoietic stem-cell transplantation (HSCT2) is a the...
耗时 0.12576 秒，为您在
48322673
条记录里面共找到 2587 篇文章 [XML]